サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：声帯補強の世界市場-2023-2030
市場調査レポート
商品コード
1272776

声帯補強の世界市場-2023-2030

Global Vocal Fold Augmentation Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
声帯補強の世界市場-2023-2030
出版日: 2023年05月15日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

声帯補強の世界市場は、2022年に20億4,280万米ドルに達し、2030年には26億4,280万米ドルに達することで有利な成長が予測されています。声帯補強市場は、予測期間中（2023-2030年）に3.3%のCAGRを示すと予測されています。主要企業は、M&A、パートナーシップ、地域拡大などの戦略を採用し、声帯補強市場で強力な競争相手として際立つことを目指しています。研究開発への重点的な取り組みとともに、新製品の発売は、主要企業が市場での存在感を高める他の方法です。

例えば、2020年11月6日、Thyssen'sche Handelsgesellschaft mbH（THG）は、SPIGGLE &THEIS Medizintechnik GmbH（「SPIGGLE &THEIS」）の過半数の株式を即効で取得しました。さらに、2020年12月18日、APreventとhearLIFEは、韓国、シンガポール、マレーシア、タイ、インドネシア、ベトナム、カンボジア、ラオス、ミャンマー、ブルネイにおけるAPrevent VOISの独占販売契約に調印しました。

市場参入企業による地理的な足跡の拡大や、複数の製品の発売や新興国市場開拓による顧客層の強化といった競合要因が、予測期間中の市場成長を促進すると予想されます。

声帯補強は、声帯の機能を強化するために行われる医療処置です。声帯萎縮、麻痺、麻痺などの軽度から中等度の声門閉鎖不全の様々な永久的な原因を治療するために、声帯注射を使用することが含まれます。さらに、以前の枠組み手術後の増強にも使用することができます。

声帯補強の世界市場は、声に関連する問題の症例の増加、ヘルスケアに対する意識の高まり、技術の進歩などのさまざまな要因によって、今後数年間で大きな成長を遂げることが予想されます。

さらに、老年人口の増加や低侵襲手術の需要の高まりも、市場の成長を後押しすると予想されています。また、過去10年間に声帯注射がさまざまな喉頭疾患に対する貴重な治療法として登場したことも、市場の成長に寄与しています。

市場力学

喉頭がん患者数の増加が、声帯補強の世界市場の成長を促進すると予想されます

世界の声帯補強市場は、喉頭がんを含む声の問題の有病率の増加によって牽引されています。例えば、米国がん協会によると、喉頭がんの新規症例は毎年約13,150件あり、HPV感染、タバコ使用、アルコール摂取などの危険因子が症例増加の要因になっています。その結果、喉頭障害患者の発声機能を改善するための声帯補強術の需要が高まっています。

声帯補強の世界市場は、熟練した専門家の不足別制約に直面する可能性があります

声帯補強市場は、質の高い医療従事者への需要が高まる中、ヘルスケア従事者の不足にも影響されます。usnews.comによると、米国では2025年までに、ホームヘルパー、看護助手、医療・検査技師・技術者、看護師など、いくつかの医療専門職の不足に直面すると推定されています。これらの不足は、特定の職業において最も顕著かつ劇的であり、声帯形成術や治療に対する需要を満たす上での課題につながる可能性があります。

COVID-19の影響分析

COVID-19の流行は、世界の声帯補強市場に大きな影響を与え、医療機器や装置のサプライチェーンや製造に混乱を引き起こしました。その結果、遅延や不足が発生し、市場における製品やサービスの入手に影響を及ぼしました。さらに、多くの医療施設では、COVID-19患者を優先し、感染リスクを低減するために、声帯補強手術を含む選択的処置を縮小または延期しています。

しかし、こうした課題にもかかわらず、音声障害の有病率の増加や、市場における革新的な手術技術や新製品への需要の高まりにより、パンデミックの状況が改善されれば、市場は回復すると予想されます。また、多くのメーカーやサービスプロバイダーは、遠隔医療サービスの提供や、ヘルスケア専門家向けのバーチャルトレーニングやサポートプログラムの開発によって、パンデミックに適応しています。

ロシア・ウクライナ紛争の分析

現在のロシアとウクライナの紛争は、製造・流通経路を遮断することで声帯補強市場に間接的な影響を与える可能性があり、その結果、供給不足と製品のコスト上昇が生じ、中小企業への影響が大きくなる可能性があります。

しかし、こうした課題にもかかわらず、ヘルスケアに対する意識の高まりや音声関連疾患の有病率の上昇により、市場は長期的に拡大すると予測されています。このことは、同業他社にビジネスチャンスをもたらすと期待されます。戦争や進行中のパンデミックの短期的な影響により混乱が生じる可能性もありますが、長期的には市場は回復し、引き続き繁栄すると予測されます。そのため、紛争が世界のヘルスケア産業全体に与える影響を追跡することが極めて重要です。

目次

第1章 調査手法と範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

  • 素材タイプ別スニペット
  • トリートメントタイプ別
  • エンドユーザー別
  • 地域別スニペット

第4章 市場力学

  • 影響要因
    • 促進要因
      • 喉頭がん患者の増加は、世界の声帯補強市場の成長を促進すると予想
    • 抑制要因
      • 熟練した専門家の不足により、世界の声帯補強市場の成長は制約を受ける可能性
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 法規制の分析

第6章 COVID-19の分析

  • COVID-19の分析
    • COVID-19登場前シナリオ
    • 現在のCOVID-19シナリオ
    • COVID-19後または将来のシナリオ
  • COVID-19の中での価格・ダイナミクス
  • 需給スペクトル
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • サマリー

第7章 素材タイプ別

  • カルボキシメチルセルロース
  • カルシウムハイドロキシアパタイト
  • ヒアルロン酸
  • シルク
  • ジェルフォーム
  • 油脂類
  • その他

第8章 治療タイプ別

  • 一時的なもの
  • 恒久的なもの

第9章 エンドユーザー別

  • 病院
  • 専門医院
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A（合併・買収）分析

第12章 企業プロファイル

  • Merz Holding GmbH & Co KG（Merz Pharmaceuticals, LLC）
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展状況
  • Sofregen Medical Inc.
  • Hoya Corporation（PENTAX Medical America, Inc.）
  • SPIGGLE & THEIS Medizintechnik GmbH
  • Inhealth Technologies
  • APrevent Medical Inc.
  • Boston Medical Products, Inc.
  • ReGen Scientific

第13章 付録

目次
Product Code: MD818

Market Overview

The global vocal fold augmentation market reached US$ 2,042.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 2,642.8 million by 2030. The vocal fold augmentation market is expected to exhibit a CAGR of 3.3% during the forecast period (2023-2030). The key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the vocal fold augmentation market. New product launches along with increased focus on R&D are other ways the leading players improve their market presence.

For instance, on November 6, 2020, Thyssen'sche Handelsgesellschaft mbH (THG) acquired a majority stake in SPIGGLE & THEIS Medizintechnik GmbH ("SPIGGLE & THEIS") with immediate effect. Moreover, on December 18, 2020, APrevent and hearLIFE signed the exclusive distribution agreement for APrevent VOIS in Korea, Singapore, Malaysia, Thailand, Indonesia, Vietnam, Cambodia, Laos, Myanmar, and Brunei.

Fierce competition between market participants to expand their geographic footprints and strengthen their customer pool through several product launches & new product developments are major factors anticipated to drive market growth over the forecast period.

Vocal fold augmentation is a medical procedure that is performed to enhance the functioning of the vocal folds. It involves the use of vocal fold injection to treat various permanent causes of mild-to-moderate glottic insufficiency, such as vocal fold atrophy, paralysis, and paresis. Moreover, it can also be used for augmentation after previous framework surgery.

The global vocal fold augmentation market is expected to experience significant growth in the coming years, driven by various factors such as increasing cases of voice-related problems, rising awareness of healthcare, and advancements in technology.

Moreover, the growing geriatric population and rising demand for minimally invasive procedures are also expected to boost the market's growth. The emergence of vocal fold injection as a valuable treatment modality for a variety of laryngeal disorders in the past decade is also contributing to the market's growth.

Market Dynamics

The rising number of laryngeal cancer cases is expected to drive the growth of the global vocal fold augmentation market

The global vocal fold augmentation market is being driven by the increasing prevalence of voice problems, including laryngeal cancer. For instance, The American Cancer Society reports that there are around 13,150 new cases of laryngeal cancer each year, with risk factors such as HPV infection, tobacco use, and alcohol consumption contributing to the rise in cases. As a result, there is an increasing demand for vocal fold augmentation procedures to improve vocal function in patients with laryngeal disorders.

The global vocal fold augmentation market growth may face constraints due to a lack of skilled professionals

The vocal fold augmentation market is also affected by shortages in the healthcare workforce, as the demand for quality healthcare professionals increases. According to usnews.com, the U.S. is estimated to face shortages in several healthcare professions by 2025, including home health aides, nursing assistants, medical and lab technologists and technicians, and nurse practitioners. These shortages are most apparent and dramatic in certain professions, which could lead to challenges in meeting the demand for vocal fold augmentation procedures and treatments.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the global vocal fold augmentation market, causing disruptions in the supply chain and manufacturing of medical devices and equipment. This has resulted in delays and shortages, affecting the availability of products and services in the market. Moreover, many healthcare facilities have reduced or postponed elective procedures, including vocal fold augmentation surgeries, to prioritize COVID-19 patients and reduce the risk of transmission.

However, despite these challenges, the market is expected to recover as the pandemic situation improves, driven by the growing prevalence of voice disorders and the increasing demand for innovative surgical techniques and new products in the market. Many manufacturers and service providers have also adapted to the pandemic by offering telemedicine services and developing virtual training and support programs for healthcare professionals.

Russia-Ukraine Conflict Analysis

The current conflict between Russia and Ukraine could have an indirect effect on the vocal fold augmentation market by interrupting the manufacturing and distribution channels, resulting in shortages of supplies and higher costs for products that could have a greater impact on smaller firms.

However, despite these challenges, the market is projected to expand in the long run due to a growing awareness of healthcare and the rising prevalence of voice-related disorders. This is expected to create business opportunities for companies in the industry. Although the short-term effects of the war and the ongoing pandemic may cause disruptions, the market is predicted to rebound and continue to thrive over time. As a result, it is crucial to track the impact of the conflict on the global healthcare industry as a whole.

Segment Analysis

The global vocal fold augmentation market is segmented based on material type, treatment type, end user, and region.

The carboxymethylcellulose segment is expected to hold the highest vocal fold augmentation market share

The carboxymethylcellulose segment is expected to be the dominant segment in the global vocal fold augmentation market, holding 30.7% of the market share over the forecast period. The use of carboxymethylcellulose vocal cord injection is expected to be the leading technique in the global vocal fold augmentation market. Carboxymethylcellulose (CMC) is a thickening agent derived from cellulose obtained from materials such as wood pulp or cotton lint, which is reacted with a derivative of acetic acid (found in vinegar) and is also referred to as cellulose gum.

Gels made from carboxymethylcellulose (CMC) and cross-linked hyaluronic acid are commonly used as injectable materials for temporary or resorbable vocal fold medialization. For example, PROLARYN GEL, an aqueous/glycerin/carboxymethylcellulose gel implant, is used to augment the size of displaced or deformed vocal folds so that they can meet the opposing fold in the midline, leading to improved phonation. PROLARYN GEL is particularly suitable for short-term vocal fold augmentation or for patients who want to evaluate augmentation before undergoing long-term procedures.

Geographical Analysis

The presence of major players to dominate the North America region.

The vocal fold augmentation market is expected to grow significantly in North America region over the forecast period due to the presence of key market players who hold a major global vocal fold augmentation market share of around 2/5th and also due to an increase in cases of vocal fold paresis or paralysis (VFP) caused by COVID-19 vaccination, leading to dysphonia and respiratory distress.

To address these issues, several companies, such as Sofregen Medical, Inc., are developing products like Silk Voice, a soft tissue bulking agent injection that helps with vocal fold medialization and insufficiency. Silk Voice injection helps improve phonation by increasing the size of the displaced or malformed vocal fold, allowing it to converge with the opposing fold at the midline. An urgent indication for Silk Voice injection could be vocal fold insufficiency and severe aspiration issues.

Competitive Landscape

The major global players in the market include Merz Holding GmbH & Co KG(Merz Pharmaceuticals, LLC), Sofregen Medical Inc., Hoya Corporation(PENTAX Medical America, Inc.), SPIGGLE & THEIS Medizintechnik GmbH, Inhealth Technologies, APrevent Medical Inc., and Boston Medical Products, Inc., among others.

Why Purchase the Report?

  • To visualize the global vocal fold augmentation- market segmentation based on material type, treatment type, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global vocal fold augmentation market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global vocal fold augmentation market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Material Type
  • 3.2. Snippet by Treatment Type
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising number of laryngeal cancer cases is expected to drive the growth of the global vocal fold augmentation market.
    • 4.1.2. Restraints
      • 4.1.2.1. The global vocal fold augmentation market growth may face constraints due to lack of skilled professionals.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Material Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.1.2. Market Attractiveness Index, By Material Type
  • 7.2. Carboxymethylcellulose
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Calcium Hydroxylapatite
  • 7.4. Hyaluronic Acid
  • 7.5. Silk
  • 7.6. Gelfoam
  • 7.7. Fats
  • 7.8. Others

8. By Treatment Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 8.1.2. Market Attractiveness Index, By Treatment Type
  • 8.2. Temporary
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Permanent

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Merz Holding GmbH & Co KG (Merz Pharmaceuticals, LLC) *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Sofregen Medical Inc.
  • 12.3. Hoya Corporation (PENTAX Medical America, Inc.)
  • 12.4. SPIGGLE & THEIS Medizintechnik GmbH
  • 12.5. Inhealth Technologies
  • 12.6. APrevent Medical Inc.
  • 12.7. Boston Medical Products, Inc.
  • 12.8. ReGen Scientific

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us